Aristeia Capital L.L.C. Sells 9,647 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Aristeia Capital L.L.C. reduced its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 64.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,276 shares of the company's stock after selling 9,647 shares during the quarter. Aristeia Capital L.L.C.'s holdings in Bath & Body Works were worth $205,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Golden State Wealth Management LLC purchased a new position in shares of Bath & Body Works during the 4th quarter worth $26,000. SRS Capital Advisors Inc. lifted its stake in Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after buying an additional 329 shares during the last quarter. UMB Bank n.a. increased its stake in Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares during the period. Lindbrook Capital LLC increased its holdings in shares of Bath & Body Works by 81.9% in the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after purchasing an additional 431 shares during the period. Finally, Wilmington Savings Fund Society FSB purchased a new position in Bath & Body Works during the third quarter worth about $39,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have issued reports on BBWI. Telsey Advisory Group reiterated an "outperform" rating and issued a $43.00 price objective on shares of Bath & Body Works in a research report on Thursday, February 27th. Piper Sandler upgraded Bath & Body Works from a "neutral" rating to an "overweight" rating and dropped their target price for the company from $38.00 to $35.00 in a research note on Wednesday, April 9th. Barclays cut their price target on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating on the stock in a research note on Monday, March 3rd. Citigroup reduced their price objective on Bath & Body Works from $48.00 to $36.00 and set a "buy" rating on the stock in a research note on Monday, April 7th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Bath & Body Works from $47.00 to $41.00 and set an "overweight" rating on the stock in a report on Monday, April 14th. Four investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $41.88.

Bath & Body Works Stock Performance

Shares of BBWI stock traded down $0.51 on Friday, reaching $31.23. 963,736 shares of the company's stock traded hands, compared to its average volume of 4,785,779. Bath & Body Works, Inc. has a 12-month low of $24.96 and a 12-month high of $52.99. The company has a market capitalization of $6.65 billion, a P/E ratio of 7.62, a price-to-earnings-growth ratio of 0.92 and a beta of 1.87. The business's 50 day moving average price is $29.89 and its two-hundred day moving average price is $33.78.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works declared that its Board of Directors has approved a share buyback plan on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 6.4% of its shares through open market purchases. Shares buyback plans are often an indication that the company's board believes its stock is undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.